KEY FACTS
Terminology
- •
Synonyms: Mucinous cystic neoplasm, macrocystic cystadenoma/carcinoma, mucinous cystadenoma/carcinoma
- •
Septated cystic neoplasm composed of mucin-producing epithelium and distinctive ovarian-type stroma, ranging in grade from potentially malignant to invasive carcinoma
Imaging
- •
Solitary, uni- or multilocular, well-circumscribed cystic lesion in body or tail of pancreas
- •
Echogenic septations
- •
Typically < 6 cystic components, which are each > 2 cm in size
- •
Cyst contents may be anechoic or echogenic with debris representing mucin
- •
May contain peripheral calcification
- •
2 cm to > 10 cm in diameter; mean: 8.7 cm
- •
No communication with pancreatic duct
- •
Mural nodularity and solid component suggest malignancy
- •
Contrast-enhanced CT or MR used to accurately characterize morphology and guide treatment
- •
Endoscopic US: Invasive technique reserved for when fine-needle aspiration is being considered
- •
Hypovascular on color Doppler (nodules and septations may show flow)
Top Differential Diagnoses
- •
Intraductal papillary mucinous neoplasm
- •
Macrocystic variant of serous cystadenoma
- •
Solid pseudopapillary tumor
- •
Pseudocyst
- •
Cystic pancreatic neuroendocrine tumor
Clinical Issues
- •
Seen almost exclusively in middle-aged women; termed “mother lesion”; mean age: 50 years
- •
M:F = 1:20
- •
10% of cystic pancreatic tumors
- •
Often asymptomatic
- •
May present with epigastric pain, palpable mass, or fullness
- •
Excellent prognosis without invasive carcinoma
- •
All tumors in this class are considered surgical lesions
- •
Worse prognosis when invasive carcinoma is present; however, better than with typical ductal-type adenocarcinoma (75% vs. 5%)
Scanning Tips
- •
Findings on US are nonspecific and further evaluation with CT or MR is necessary